Date Title Alternative
2024-03-01 Coverage paused Download | Show Close
2024-01-31 Volume update on UK project Download | Show Close
2023-11-15 Guidance reiterated, but with reduced visibility Show Close
2023-10-04 A new deal Show Close
2023-08-15 Full-year guidance suggests growth has returned Show Close
Research | 15 Aug 2023 | Irisity

Full-year guidance suggests growth has returned

 

Ongoing delivery by the company

Revenues reached SEK 30.2m in the quarter, representing growth of -5% y/y and 10% q/q. MRR came in at SEK 4.5m, implying 2% growth q/q. EBITDA for Q2 was SEK 0.3m, suggesting a margin of 1%. The driving force behind the positive EBITDA was the gross margin hitting 83.9%. During Q2, the company forged two new strategic alliances, the first with Exanet, a surveillance company focusing on the Latin American markets, and the other with Mobius, a security company focused on the Middle East. To increase transparency, Irisity has presented full-year and quarterly guidance, the full-year guidance suggesting sales of SEK 131–141m. It anticipates sales of SEK 32–37m in Q3 and of SEK 37–42m in Q4.

Strong belief in the technology

We have confidence in Irisity’s technology, thanks to the technical validation it has received from several large players in the field. In Q4, the company signed two framework agreements with key players in the ecosystem. Moreover, interest in the industry for software investments that facilitate surveillance work is substantial. During 2022, Irisity had repeated problems with project delivery. We believe this was partly the result of winning larger and more complex projects for which it lacked the full delivery capacity. We consider the robust growth q/q and issued full-year guidance proof that Irisity can deliver.

 

Estimat raised to reflect new guidance

Given the quarter’s sales and that we assume that Irisity will see a continued growth in MRR during the current year we lift our net sales estimates by around 7%. Our new estimate is at the lower end of the guidance range for this year. Furthermore we believe that the growth will continue in the period 2024 2025 and we raise or estimates during the period by an average of 11%. Led by the company’s higher gross margin, we lift our EBITDA estimates by SEK 8m for 2023, by SEK 9m for 2024, and by SEK 10m for 2025. The quarter, a continued growth in MRR, the directed share issue and the confidence of the new management makes us look forward to H2’23. We reiterate our positive view on the technology and keep our fair value at SEK 9.1-9.5.

 

2023-05-15 Working through 2022 order book Show Close
2023-02-28 Order book shows growth returning Show Close
2022-11-15 Most challenges lie ahead Show Close
2022-08-17 Organic growth accelerates Show Close
2022-05-25 Capital Market Day sets the pace going forward Show Close
2022-02-21 MRR growth and gross margin reach record highs Show Close
2021-08-09 Accelerating growth Show Close
2021-05-10 In line with our expectations and confirms commercialization plan Show Close